Accuratus Lab Services is committed to remaining at the forefront of scientific methods and providing outstanding testing services. Accuratus staff scientists Becky Lien and Shanen Conway attended ASTM Committee Week in San Diego recently to participate in ongoing revisions to scientific methods and practices. In addition, Accuratus has chosen to Champion revisions to E1053 (Virucidal Disinfection) standards… Read More
Posted on: April 20, 2018
Accuratus Lab Services has been a committed partner to the developers, manufacturers and users of antimicrobial products for over 25 years. We provide clients with a comprehensive range of microbiology, virology and analytical chemistry testing services. Watch our video to learn more about how Accuratus can partner with you on your testing needs. And Contact… Read More
Posted on: April 17, 2018
On February 28, 2018, the Environmental Protection Agency released final 810 guidelines for 810.2000, 810.2100 and 810.2200. Read on for a summary of critical changes made to the 810 guidelines.
Posted on: March 19, 2018
Visit Accuratus Lab Services at Booth #1352 at MD&M Anaheim this week, Feb. 6-8. Accuratus wants to put its reusable medical device testing expertise to work for you. Our reusable medical device testing facilities are U.S. FDA-regulated to meet all GLP standards (21 CFR Part 58). Our labs are staffed by highly educated, trained, experienced… Read More
Posted on: February 6, 2018
In addition to providing the highest quality antimicrobial efficacy testing services in the industry, Accuratus Lab Services also offers analytical chemistry testing to provide a streamlined approach to product registration.
Posted on: November 6, 2017
Accuratus to attend the PDA Micro 12th Annual PDA Global Conference on Pharmaceutical Microbiology – Parenteral Drug Association, booth #111
12th Annual PDA Global Conference on Pharmaceutical Microbiology Solving Microbiological Challenges and Sustaining Success through a Culture of Collaboration
Posted on: September 28, 2017
Reusable Medical Device manufacturers are required by the US Food and Drug Administration to validate their reprocessing instructions. Statistics say, about one in 25 hospital patients has at least one healthcare-associated infection. With adequate reprocessing instructions, we can help reduce these statistics!
Posted on: September 7, 2017